SCHEMBL22891912

SCHEMBL22891912

CCCCCC(C)C(C)c1cc(C)c2c(c1)CC(C)(C)C=C2c1ccncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonabine SCHEMBL2111682 0.71 KDR (0.32) —
SCHEMBL17414514 0.71 KDR (0.33) —
SCHEMBL11819864 0.60 AAK1 (0.37) —
SCHEMBL9285694 0.59 CNR2 (0.45) —
SCHEMBL24919761 0.59 MAPT (0.41) —
SCHEMBL11711483 0.58 RPS6KA3 (0.41) —
SCHEMBL24920240 0.58 SLC6A2 (0.44) —
SCHEMBL68774 0.57 ADRB2 (0.54) —
SCHEMBL9663065 0.57 MAPT (0.45) —
SCHEMBL11831177 0.56 ADRB2 (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3473630-B1 BORON-BASED PRODRUG STRATEGY FOR INCREASED BIOAVAILABILITY AND LOWER-DOSAGE REQUIREMENTS FOR DRUG MOLECULES CONTAINING AT LEAST ONE PHENOL (OR AROMATIC HYDROXYL) GROUP XAVIER UNIV OF LOUISIANA (US) 2021-01-13 — — EP disclosed
Send feedback